What is Complete Ketamine Solutions?
Complete Ketamine Solutions is at the forefront of innovative ketamine therapy treatments, dedicated to offering rapid relief for individuals grappling with mental health challenges and chronic pain. Their comprehensive service portfolio includes IV ketamine infusions, IM ketamine injections, Spravato treatment, and ketamine-assisted psychotherapy. Each treatment plan is meticulously tailored to the unique requirements of every patient, emphasizing compassionate care and personalized strategies to enhance quality of life. With a growing presence across multiple U.S. locations, the company addresses critical needs for effective solutions for treatment-resistant depression, PTSD, anxiety disorders, and various chronic pain syndromes.
How much funding has Complete Ketamine Solutions raised?
Complete Ketamine Solutions has raised a total of $37K across 1 funding round:
Debt
$37K
Debt (2021): $37K with participation from PPP
Key Investors in Complete Ketamine Solutions
PPP
Public-Private Partnership
What's next for Complete Ketamine Solutions?
The substantial expansion capital secured by Complete Ketamine Solutions positions the company for significant scaling and further development of its therapeutic offerings. As they operate within the significant Series B/C stage, this investment is likely earmarked for expanding their geographic footprint, enhancing clinical research, and potentially broadening their service modalities. The focus on ketamine therapy for mental health and chronic pain aligns with a growing demand for alternative and rapid-acting treatment options, suggesting a strategic trajectory aimed at capturing a larger share of this burgeoning market.
See full Complete Ketamine Solutions company page
